Congenital erythrocytosis

M F McMullin1

  • 1Department of Haematology, Belfast City Hospital, Queen's University Belfast, Belfast, UK.

Insights

Congenital erythrocytosis, present from birth, can stem from primary defects or secondary causes like abnormal oxygen sensing. Diagnosis involves molecular investigation, though a cause remains unidentified in many cases.

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Congenital erythrocytosis is a rare condition present at birth, often diagnosed in childhood or early adulthood.
  • It can be primary, involving erythroid compartment defects, or secondary, caused by increased erythropoietin production.
  • Family history may be present in affected individuals.

Purpose of the Study:

  • To review the causes, diagnostic approaches, and management of congenital erythrocytosis.
  • To highlight the role of molecular investigations in identifying genetic defects.
  • To discuss potential complications and therapeutic strategies.

Main Methods:

  • Review of primary causes including erythropoietin receptor mutations.
  • Investigation of congenital secondary causes involving oxygen-sensing pathways and abnormal hemoglobin oxygen affinity.
  • Diagnostic procedures include erythropoietin levels, oxygen dissociation curves, hemoglobin electrophoresis, and gene sequencing.

Main Results:

  • Identification of known or novel molecular variants confirms congenital erythrocytosis.
  • Nonspecific symptoms can occur, and major thromboembolic events have been reported.
  • Therapeutic options include low-dose aspirin and venesection.

Conclusions:

  • Congenital erythrocytosis is a rare condition often presenting in young individuals.
  • Molecular investigations can identify underlying genetic lesions.
  • In a majority of cases, no specific genetic defect is currently identified.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.6K
Erythropoiesis01:14

Erythropoiesis

4.0K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.7K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
996